MedMira receives Health Canada approval for its Reveal® G4 Rapid HIV-1/2 Test for Point-of-Care use

Halifax, Nova Scotia – January 14, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received today the approval from Health Canada for its Reveal® Rapid G4 HIV-1/2 Test (Reveal® HIV test) for Point-of-Care (POC) use. The Reveal® HIV rapid test has achieved a sensitivity of 99.64% and a specificity of 99.71% […]
Miriad® MultiLinx™ – One Test, More Answers

Introducing MedMira’s latest product now available anywhere for Tissue and Eye Banks: Miriad MultiLinx: One Test, More Answers. The fastest answer to HIV, Syphilis, Hepatitis C (Antibodies) and HBeAg and HBsAG (Antigen) – in ONE test.